Advertisement

Molecular Basis for the Substrate Specificity of Human Catecholamine Sulfotransferase, SULT1A3

  • Michael W. H. Coughtrie
  • Jyrki Taskinen
  • Alan M. Hood
Part of the Advances in Behavioral Biology book series (ABBI, volume 53)

Abstract

Sulfation is an important component of the body’s chemical defence mechanism, and provides a major route for the metabolism, detoxification and elimination of a host of xenobiotics (Coughtrie 1996). In addition to this role, sulfation also functions in the homeostasis of a number of important endogenous compounds, including iodothyronines (Visser 1996), steroid hormones (Roy 1992), oxysterols (Javitt et al. 2001) and catecholamines (Goldstein et al. 1999). These reactions are catalysed by members of the sulfotransferase (SULT) enzyme superfamily that transfer a sulfuryl moiety from the co-substrate 3′-phopshoadenosine 5′-phosphosulfate (PAPS). In humans, the SULT family numbers at least 11 members derived from at least 10 genes. The human SULTs can be subdivided into 3 different subfamilies based on amino acid sequence similarity and functional activity, and the largest family, SULT1 or phenol SULT, currently comprises 7 members (Coughtrie et al. 2001). Humans (and other primates) differ from most animal species in that they have significant levels of circulating catecholamine sulfates; for example up to 98% of circulating dopamine is in its sulfated form (Goldstein et al. 1999). It is believed that the gastrointestinal tract is the major source of these circulating catecholamine sulfates (Goldstein et al. 1999), and indeed significant increases in plasma dopamine sulfate can be observed after ingestion of bananas (Davidson et al. 1981) which are rich in dopamine (Kanazawa et al. 2000).

Keywords

Amino Acid Sequence Similarity Catecholaminergic System Enzyme Superfamily Detailed Amino Acid Ethylamine Side Chain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bidwell L. M., McManus M. E., Gaedigk A., Kakuta Y. et al., 1999, Crystal structure of human catecholamine sulfotransferase. J Mol Biol, 293: 521–530.PubMedCrossRefGoogle Scholar
  2. Brix L. A., Duggleby R. G., Gaedigk A., and McManus M. E., 1999, Structural characterization of human aryl sulphotransferases. Biochem J, 337: 337–343.PubMedCrossRefGoogle Scholar
  3. Coughtrie M. W. H., 1996, Sulphation catalysed by the human cytosolic sulphotransferases — chemical defence or molecular terrorism? Hum Exp Toxicol, 15: 547–555.PubMedCrossRefGoogle Scholar
  4. Coughtrie M. W. H., and Johnston L. E., 2001, Interactions between dietary chemicals and human sulfotransferases — Molecular mechanisms and clinical significance. Drug Metab Dispos, 29: 522–528.PubMedGoogle Scholar
  5. Dajani R., Cleasby A., Neu M., Wonacott A. J. et ai, 1999, X-ray crystal structure of human dopamine sulfotransferase, SULT1A3: Molecular modelling and QSAR analysis demonstrate a molecular basis for sulfotransferase substrate specificity. J Biol Chem, 274: 37862–37868.PubMedCrossRefGoogle Scholar
  6. Dajani R., Hood A. M., and Coughtrie M. W. H., 1998, A single amino acid, Glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3. Mol Pharmacol, 54: 942–948.PubMedGoogle Scholar
  7. Davidson L., Vandongen R., and Beilin L. J., 1981, Effect of eating bananas on plasma free and sulfate-conjugated catecholamines. Life Sci., 29: 1773–1778.PubMedCrossRefGoogle Scholar
  8. Dooley T. P., 1998, Molecular biology of the human phenol sulfotransferase gene family. Journal Of Experimental Zoology, 282: 223–230.PubMedCrossRefGoogle Scholar
  9. Goldstein D. S., Swoboda K. J., Miles J. M., Coppack S. W. et ai, 1999, Sources and physiological significance of plasma dopamine sulfate. J Clin Endocrinol Metab, 84: 2523–2531.PubMedCrossRefGoogle Scholar
  10. Javitt N. B., Lee Y. C., Shimizu C., Fuda H. et al., 2001, Cholesterol and hydroxycholesterol sulfotransferases: Identification, distinction from dehydroepiandrosterone sulfotransferase, and differential tissue expression. Endocrinology, 142: 2978–2984.PubMedCrossRefGoogle Scholar
  11. Kakuta Y., Pedersen L. G., Carter C. W., Negishi M. et ai, 1997, Crystal structure of estrogen sulphotransferase. Nature Struct Biol, 4: 904–908.PubMedCrossRefGoogle Scholar
  12. Kakuta Y., Petrotchenko E. V., Pedersen L. C., and Negishi M., 1998, The sulfuryl transfer mechanism: crystal structure of a vanadate complex of estrogen sulfotransferase and mutational analysis. J Biol Chem, 273: 27325–27330.PubMedCrossRefGoogle Scholar
  13. Kanazawa K., and Sakakibara H., 2000, High content of dopamine, a strong antioxidant, in Cavendish banana. J Agr Food Chem, 48: 844–848.CrossRefGoogle Scholar
  14. Rein G., Glover V., and Sandler M., 1982, Mutiple forms of phenolsulphotransferase in human tissues. Selective inhibition by dichloronitrophenol. Biochem Pharmacol, 31: 1893–1897.PubMedCrossRefGoogle Scholar
  15. Richard K., Hume R., Kaptein E., Stanley E. L. et ai, 2001, Sulfation of thyroid hormone and dopamine during human development — ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung and brain. J Clin Endocrinol Metab, 86: 2734–2742.PubMedCrossRefGoogle Scholar
  16. Roy A. K., 1992, Regulation of steroid hormone action in target cells by specific hormone-inactivating enzymes. Proc Soc Exp Biol Med, 199: 265–272.PubMedGoogle Scholar
  17. Rubin G. L., Sharp S., Jones A. L., Glatt H. et ai, 1996, Design, production and characterisation of antibodies discriminating between the phenol- and monoamine-sulphating forms of human phenol sulphotransferase. Xenobiotica, 26: 1113–1119.PubMedCrossRefGoogle Scholar
  18. Visser T. J., 1996, Pathways of thyroid hormone metabolism. Acta Med Austriaca, 1/2: 10–16.Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Michael W. H. Coughtrie
    • 1
  • Jyrki Taskinen
    • 2
  • Alan M. Hood
    • 1
  1. 1.Department of Molecular & Cellular Pathology, Ninewells Hospital & Medical SchoolUniversity of DundeeDundeeScotland, UK
  2. 2.Division of Pharmaceutical Chemistry, Department of PharmacyUniversity of HelsinkiHelsinkiFinland

Personalised recommendations